Updated:
Advanced MedTech Holdings
Advanced MedTech Holdings operates a vertically integrated medical device business. The company holds a market position in urological stone treatment.
Advanced MedTech Holdings
Advanced MedTech Holdings operates a vertically integrated medical device business. The company holds a market position in urological stone treatment.
General information
Firm type
Asset Manager
Location
Region
North America
Country
Singapore
City
Singapore
Corporate office
Singapore, Singapore
Additional offices
Marlborough, United States · Tokyo, Japan
Sector focus
Frequently asked questions
Who owns Advanced MedTech Holdings?
Advanced MedTech Holdings is wholly owned by Temasek Holdings, the Singapore state investment company (per the firm's website).
What medical specialties does Advanced MedTech focus on?
The company focuses on urology, specifically stone management (lithotripsy) and prostate health, as well as robotic surgery tools (per the firm's website).
What are the operating subsidiaries of Advanced MedTech Holdings?
AMTH's group companies include Dornier MedTech, WIKKON, Northern Litho, NextMed, and AMT Pte. Ltd. for manufacturing (per the firm's website).
Where is Advanced MedTech Holdings headquartered?
The firm is headquartered in Singapore, with additional offices in Marlborough, United States, and Tokyo, Japan (per the firm's website).
Does Advanced MedTech disclose its financials?
No, the firm does not publicly disclose its AUM, revenue, or profit figures. The website describes the company as "profitable, high-growth" but provides no specific numbers.
How does Advanced MedTech Holdings relate to Temasek?
AMTH is a wholly owned portfolio company of Temasek Holdings, the Singapore sovereign wealth fund. This provides AMTH with long-term capital and strategic support.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on asset managers?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: